production. Pericytes expressed angiotensin II (Ang II) receptors, and Ang II upregulated Nox4 expression. Hypoxic conditions also increased the Nox4 expression. Silencing of Nox4 significantly reduced ROS production and attenuated cell proliferation. Conclusion: Our study showed that Nox4 is a major superoxide-producing enzyme and that its expression is regulated by Ang II and hypoxic stress in human brain pericytes. In addition, Nox4 may promote cell growth.
Introduction
Pericytes are multifunctional cells surrounding microvessels, such as capillaries and postcapillary venules [1] , and interact closely with vascular endothelial cells, modulate endothelial function and regulate microvascular blood flow [2, 3] . Although pericytes exist on microvessels in all organs, the density of pericytes varies according to the function of the vessel and organ in which the cells reside. The highest density of pericytes in the body is found in vessels of neural tissues, such as the brain and retina [1, 4] . In cerebral vessels, pericytes are proposed to have important roles in the regulation of cerebral microcirculation and angiogenesis, maintenance of the blood-brain barrier, and immune response [5] [6] [7] [8] [9] .
In vascular walls, reactive oxygen species (ROS) appear to play a pivotal role in a variety of pathophysiological processes, such as the development of arteriosclerosis and disturbance of vessel tone regulation [10] [11] [12] [13] . Recent evidence has suggested that the major source of ROS in the vascular wall is NADPH oxidase (Nox) [14] [15] [16] . The Nox family enzymes are dedicated to ROS production. The founder member of the Nox family is gp91 phox , a membrane-spanning protein, which is predominantly expressed in professional phagocytes and has a crucial role in killing microorganisms [17] . p22 phox , another membrane-integrated protein, forms a heterodimer with gp91 phox , thereby stabilizing gp91 phox [17] [18] [19] . ROS are also produced in non-phagocytic cells, such as vascular cells. Seven members of the Nox family have been identified so far (Nox1-5 and Duox 1 and 2; gp91 phox was renamed as Nox2). Nox family members including Nox1, Nox3, Nox4, and p22
phox also form heterodimers, stabilizing each other [17] [18] [19] . We have shown previously that Nox4 is expressed abundantly in the vascular smooth muscle and endothelial cells [20] [21] [22] . However, the expression of Nox enzymes in pericytes is still unknown. Thus, the aims of the present study were to investigate the expression of Nox enzymes, monitor the production of ROS, and identify the functional role and regulation of Nox enzymes in brain microvascular pericytes.
Methods
Cell Culture Human brain microvascular pericytes were purchased from the Applied Cell Biology Research Institute and cultured in CS-C complete medium (Cell Systems Corp., Kirkland, Wash., USA) containing 10% (v/v) fetal bovine serum. The manufacturer confirmed that the cells scarcely exhibited cytoplasmic uptake of Dil-Ac-LDL, inducible expression of E-Selectin (CD 62E), and expression of von Willebrand Factor (vWF), and did express vimentin intermediate filaments. Cells of passage 4-10 were used for experiments.
RT-PCR
Total RNA of indicated cells were prepared using TRIZOL reagent (Life Technologies Inc., Carlsbad, Calif., USA). Total RNA were subjected to reverse-transcription polymerase chain reaction (RT-PCR) using the ReverTra Ace qPCR RT kit (TOYOBO, Osaka, Japan) with pairs of specific primers: 5 ′ -CACTGCCT G TCCCCTATGAT-3 ′ (forward primer) and 5 ′ -ACAGTCTG CA CTGCGTTCAC-3 ′ (reverse primer) for platelet-derived growth factor receptor-β (PDGFR-β); 5 ′ -ACACAAGTGTCTG GCTGA GG-3 ′ (forward primer) and 5 ′ -CAACAGAGCCATTG GTGCA G-3 ′ (reverse primer) for vWF; 5 ′ -CTGGAGGTTGAGA GGGA CAA-3 ′ (forward primer) and 5 ′ -CTCCAGCGACT CAATCTT CC-3 ′ (reverse primer) for glial fibrillary acidic protein (GFAP); 5 ′ -GCAAGATCTGTTGTTATGCACCCATCCAA-3 ′ (forward primer) and 5 ′ -GCTGGTACCTCAAAAATTTTCTTTGTTGAA GT-3 ′ (reverse primer) for Nox1; 5 ′ -GGAGGATCC GT GGTCA CTCACCCTTTCAA-3 ′ (forward primer) and 5 ′ -CCA CTCGAG CTCATGGAAGAGACAAGTTAG-3 ′ (reverse primer) for Nox2; 5 ′ -GCAGGATCCGTGGTAAGCCACCCCTCTG-3 ′ (forward primer) and 5 ′ -GCTGAATTCAGAAGCTCTCCTT GTTGTAA T-3 ′ (reverse primer) for Nox3; 5 ′ -GCAGGATCCGT CATAAGT CATCCCTCAGA-3 ′ (forward primer) and 5 ′ -GCT GTTAAC GTCGACTCAGCTGAAAGACTCTTTAT-3 ′ (reverse primer) for Nox4; 5 ′ -GCAGGATCCACTATCTGGCTGCACAT TCG-3 ′ (forward primer) and 5 ′ -GCTGAATTC CTAGAAATT CTCTTG GAAAAATC-3 ′ (reverse primer) for Nox5; 5 ′ -AGTGT GTTTC TACTCACGTG-3 ′ (forward primer) and 5 ′ -TTATCT GAGGG GCGGTAGGA-3 ′ (reverse primer) for angiotensin type-1 receptor (AT1R); 5 ′ -TGAGTGTTGATAGGTACCAA-3 ′ (forward primer) and 5 ′ -CCATTTCTCTAAGAGAACTG-3 ′ for angiotensin type-2 receptor (AT2R); 5 ′ -CAAGAGATGGCCAC GGCT GCT-3 ′ and 5 ′ -TCCTTCTGCATCCTGTCGGCA-3 ′ for β-actin.
Briefly, 1 μl of the reverse transcription reaction was used for PCR amplification in a volume of 50 μl containing the gene specific primers described above. PCR was performed using TaKaRa Taq Hot Start Version at 94 ° C for 5 min, followed by 30 cycles at 94 ° C for 30 s, 57 ° C for 30 s, 72 ° C for 1 min, and finally 72 ° C for 7 min. PCR products were visualized on a 1.2% (w/v) agarose gel stained with ethidium bromide.
Middle Cerebral Artery Occlusion Model and Immunofluorescence
We used a male FVB mouse aged 10 weeks. Focal brain ischemia was produced using permanent occlusion of the right middle cerebral artery (MCAO) as described previously [23, 24] . The operated mouse was sacrificed with deep anesthesia 4 days after MCAO and was perfused transcardially with ice-cold heparinized saline and 4% (w/v) paraformaldehyde. The brain was quickly removed and fresh coronal sections (2 μm thick) were fixed with 4% (w/v) paraformaldehyde in phosphate-buffered saline (PBS) for immunofluorescence. Paraformaldehyde-fixed coronal sections were embedded in the optimum cutting temperature compound and were cut into 20 μm thick slices. Sections were blocked with PBS containing 5% normal goat serum for 1 h at room temperature. Next, the sections were incubated with primary antibodies against Nox4 (Abcam, Cambridge, UK) and PDGFR-β (Cell Signaling Technology, Danvers, Mass., USA) overnight at 4 ° C. Secondary antibody (affinity-purified anti-rabbit IgG) was incubated for 30 min at room temperature. The slides were observed using Z-stack function (2 μm intervals) on a BIOREVO BZ-9000 fluorescence microscope (Keyence, Osaka, Japan). The animal experiments were approved by the animal ethics committee of Kyushu University.
Preparation of Membrane and Cytosolic Fractions of Human Brain Pericytes
The membrane fraction enriched in integral membrane and membrane-associated proteins and the cytosol fraction of human brain pericytes were prepared using the ProteoExtract Native Membrane Protein Extraction Kit (Merck Millipore, Billerica, Mass., USA) according to the manufacturer's protocol. Briefly, the cells were washed with ice-cold wash buffer, and subjected to Extraction Buffer I with Protease Inhibitor Cocktail. After incubation on ice for 10 min under gentle agitation, the resultant supernatant was transferred into a sample tube and 431 used as the cytosolic fraction. The residual attached on the plate was further subjected to Extraction Buffer II with Protease Inhibitor Cocktail. After incubation on ice for 30 min, the supernatant was transferred into a sample tube and used as the membrane fraction.
Assay for Superoxide Production Using Chemiluminescence
Superoxide production was determined as superoxide dismutase (SOD)-inhibitable chemiluminescence detected with an enhancer-containing luminol-based detection system (Diogenes; National Diagnostics, Atlanta, Ga., USA) as described previously [21, 25] . Briefly, the membrane and the cytosol fractions of human brain pericytes (5 μg protein) were suspended in 200 μl of an assay buffer composed of 100 m M potassium phosphate (pH 7.0), 10 μ M FAD, 1 m M NaN 3 , and 1 m M EGTA. After preincubation with the enhanced luminol-based substrate (200 μl), NADH or NADPH was added at a final concentration of 500 μ M . The chemiluminescence was monitored continuously using a luminometer (MiniLumat LB9506; EG&G Berthold). The reaction was terminated by the addition of SOD (100 μg/ ml).
Assay for Hydrogen Peroxide (H 2 O 2 ) Production
H 2 O 2 production was measured with an Amplex Red H 2 O 2 assay kit (Molecular Probes, Eugene, Oreg., USA) according to the manufacturer's instructions as described previously [26] . Briefly, the membrane fraction (5 μg) was suspended with a working solution containing Amplex Red (100 μ M ), horseradish peroxidase (0.2 U/ml), and 500 μ M NADH. After incubation for 30 min at room temperature, the absorbance was measured (540 nm) using a microplate reader.
RNAi for Nox4 Knockdown
RNAi was performed according to the method by Elbashir et al. [27] . The double-strand siRNAs targeting Nox4 were prepared as a 3 ′ -overhang form using sense and anti-sense oligoribonucleotides. The sequences were 5 ′ -CCUUCUUGCUGUAUAACC ATT-3 ′ (sense) and 5 ′ -UGGUUAUACAGCAAGAAGGTT-3 ′ (anti-sense) for Nox4. Silencer Negative Control #1 siRNA (Life Technologies) was used as a negative control. For transfection of human brain pericytes with siRNA, we used Nucleofector technology (Lonza, Basel, Switzerland), an electroporation-based gene transfer technique, according to the manufacturer's protocol. Briefly, human brain pericytes were suspended in the Nucleofector Solution at a final concentration of 0.5-1 × 10 6 cells/100 μl, and 1 μg of siRNA duplex was added to the sample. The sample was transferred into a certified cuvette, and subjected to the Nucleofector, which was programmed for optimized transfection of pericytes. After transfection, the cells were cultured for 48 h or longer in the medium described above, and used for the following experiments.
Quantitative Real-Time PCR mRNA expression of Nox4 and p22 phox was quantified by realtime PCR of reverse-transcribed cDNA of these cells using the LightCycler instrument (Roche, Basel, Switzerland). Primer sequences for Nox4 and p22 phox were as follows: 5 ′ -CTTCCGTTG GTTTGCAGATT-3 ′ (forward primer) and 5 ′ -TGGGTCCACAA CAGAAAACA-3 ′ (reverse primer) for Nox4; 5 ′ -GTACTTTGGT GCCTACTCCA-3 ′ (forward primer) and 5 ′ -CGGCCCGAA CATAGTAATTC-3 ′ (reverse primer) for p22 phox .
Western Blotting
Cultured cells were washed twice in PBS and homogenized in the radioimmunoprecipitation assay (RIPA) lysis buffer (50 m M Tris-HCl, pH 7.5, 150 m M NaCl, 1% (v/v) NP-40, 0.5% (w/v) deoxycholic acid, 0.1% (w/v) SDS, 5 m M EDTA, 10 m M Na 4 P 2 O 7 , 0.1 m M Na 3 VO 4 , 1 m M NaF, and protease inhibitor cocktail (Thermo Scientific, Rockford, Ill., USA)). Protein concentration was determined using the BCA Protein Assay Kit (Thermo Scientific). Samples were subjected to SDS-polyacrylamide gel electrophoresis (20 μg/lane) and then transferred onto polyvinylidene fluoride membranes. The membranes were incubated for 1 h with ECL-prime blocking reagent (GE Healthcare, Piscataway, N.J., USA) at room temperature, and probed overnight at 4 ° C with the primary antibodies against Nox4 (Abcam, Cambridge, UK) or β-actin (Sigma-Aldrich, St. Louis, Mo., USA). Membranes were then washed and incubated with secondary antibodies (1: 100,000 dilution, Cell Signaling Technology, Danvers, Mass., USA) for 30 min at room temperature. Blots were developed using Immunostar LD (WAKO, Osaka, Japan) according to the manufacturer's instructions. Quantification of each band was performed using Image J software (NIH).
Assay for Cell Proliferation
We performed a cell proliferation assay using the CellTiter 96 ® Aqueous One Solution Cell Proliferation Assay Kit (Promega, Fitchburg, Wisc., USA) containing 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium, inner salt (MTS), according to the manufacturer's instructions. Briefly, human brain pericytes were subjected to transfection with siRNA. Thereafter, the cells were seeded onto a collagen-coated 96-well plate. Forty-eight or 120 h later, 20 μl of the reagent was added into each well of the 96-well assay plate containing 100 μl of culture medium. The plate was incubated for 1 h in a humidified, 5% (v/v) CO 2 atmosphere, and then the absorbance at 490 nm was recorded using 96-well plate reader.
Statistical Analysis
All values are expressed as the mean ± SD. Statistical analyses between groups were performed by the unpaired Student t -test or one-way analysis of variance followed by a Bonferroni post hoc test. A value of p < 0.05 was considered statistically significant.
Results

Expression of Nox in Human Brain Pericytes and Microvessels in a Mouse Brain
To confirm the integrity of the purchased human brain pericytes, we checked the expression of markers for cells constituting capillaries in the brain, namely PDGFR-β (for pericytes), vWF (for endothelial cells), and GFAP (for astrocytes), using RT-PCR. We found that only PDGFR-β was expressed, indicating that the cells were pericytes ( fig. 1 a) . We investigated the expression of the Nox family members in the human brain pericytes using RT-PCR. As shown in fig. 1 b, Nox4 was highly expressed and Nox5 showed faint expression in pericytes, whereas other Nox enzymes were scarcely expressed. Immunofluorescent staining demonstrated that Nox4 was present in the cells expressing PDGFR-β in microvessels in the peri-infarct areas of a mouse stroke model ( fig. 1 c) . These results suggest that Nox4 is expressed not only in cultured brain pericytes but also in pericytes of microvessels in a mouse brain.
Superoxide Production by Human Brain Pericytes
To investigate the superoxide-producing activity of human brain pericytes, we prepared membrane and cytosolic fractions of pericytes and measured superoxideproducing activity using a chemiluminescence method. As shown in fig. 2 a, the membrane fraction produced superoxide in response to the addition of NADH as well as NADPH. The cytosolic fraction also exhibited both NADH-and NADPH-dependent superoxide producing activity, but to a lesser extent ( fig. 2 b) . To investigate the effects of cytosolic factors on superoxide-producing activity, we added the cytosolic fraction to the membrane fraction and measured the superoxide-producing activity. As shown in fig. 2 c, the addition of the cytosolic fraction had no effects. These results were consistent with the fact that cytosolic proteins are not involved in the superoxide-producing activity of Nox4.
Effects of Inhibitors on Superoxide Production by the Membrane Fraction
To investigate whether Nox4 is a source of ROS in the brain pericyte membrane, we tested the effects of inhibitors on several potential superoxide-producing enzymes. SOD completely abolished chemiluminescence, indicating that the chemiluminescence signal was produced by superoxide. Superoxide-producing activity of the membrane fraction was significantly attenuated by diphenyleneiodonium (DPI), an inhibitor of Nox enzymes, in a dose-dependent manner ( fig. 2 d) . Because DPI may inhibit other superoxide-producing flavoproteins, such as nitric oxide synthases, xanthine oxidase, and mitochondrial respiratory chain complex I NADH reductase, we tested the effects of inhibitors for these proteins, namely rotenone (a blocking agent of mitochondrial respiratory chain complex I), L-NG nitroarginine methyl ester (L-NAME) (an inhibitor of nitric oxide synthases), and oxypurinol (an inhibitor of xanthine oxidase) on NAD(P)Hdependent superoxide production. These inhibitors did 433 not reduce superoxide-producing activity, suggesting that flavoproteins other than Nox4 are not involved in the superoxide production of the pericyte membrane ( fig. 2 d) .
Inhibition of Nox4 Expression Reduces ROS Production
To further confirm that Nox4 is responsible for ROS production in brain pericytes, Nox4 was knocked down using RNAi. We confirmed that RNAi drastically inhibited Nox4 expression at both the mRNA ( fig. 3 a, b) and protein ( fig. 3 c, d ) level. Upregulation of Nox isoforms other than Nox4 was not found ( fig. 3 a) . The membrane fraction prepared from human brain pericytes transfected with siRNA targeting Nox4 exhibited significantly lower superoxide-producing activity than that of cells transfected with control RNA ( fig. 3 e) . The superoxide , rotenone (50 μ M ), L-NAME (100 μ M ), or oxypurinol (1 mM ), followed by the addition of NADH. The SOD-inhibitable chemiluminescence change was continuously monitored with Diogenes. The average value of the activity in the absence of the inhibitors was set as 100% (n = 3). * p < 0.05, * * p < 0.01.
production by Nox4 is rapidly converted to H 2 O 2 , which may also be generated directly by Nox4. The Amplex Red assay showed that knockdown of Nox4 significantly inhibited H 2 O 2 production also ( fig. 3 f) . These results suggest that Nox4 is a major source of NAD(P)H-dependent ROS production by the membrane fraction of human brain pericytes.
Nox4 Is Upregulated by Angiotensin II (Ang II) and Hypoxic Stress
We next investigated the regulation of Nox4 expression. The renin-angiotensin system (RAS) is known to work not only as a vasoconstrictor in systemic circulation but also as a mediator of various pathophysiological processes through ROS production by Nox [10] . We found that human brain pericytes expressed both the AT1R and AT2R with the predominance of the AT1R ( fig. 4 a) . Ang II upregulated the expression of Nox4 and p22 phox ( fig. 4 b) . In addition, we found that Nox4 was upregulated by hypoxia at 1% (v/v) O 2 at both the mRNA and protein level ( fig. 5 ) . After incubation for 24 h in 1% (v/v) O 2 , Nox4 was significantly increased at the mRNA level ( fig. 5 a, b) , and was gradually increased under hypoxic conditions up to 48 h at the protein level ( fig. 5 c, d) .
Role of Nox4 in Cell Proliferation
We finally examined the effect of Nox4 on cell proliferation. Knockdown of Nox4 by RNAi significantly attenuated the proliferation of pericytes ( fig. 6 a, b) , suggesting that Nox4 participates in the proliferative process of human brain pericytes. were subjected to western blotting using an antibody against Nox4. Gel image ( c ) and its quantitative analysis using imageJ ( d ) are shown. The average value of the density of bands corresponding to control cells was set as 100% (n = 4) ( d ). e , f Effect of Nox4 knockdown on the ROS-producing activity of the membrane fraction of human brain pericytes. Forty-eight h after transfection of siRNA for Nox4, NADH-dependent production of superoxide ( e ) and H 2 O 2 ( f ) of the membrane fraction was measured. The average value of the activity of control cells was set as 100% (n = 3). * p < 0.01. 
Nox4 in Human Brain
Discussion
In the present study, we demonstrated the following new findings. First, Nox4 is the predominant Nox protein in human brain pericytes. Second, Nox4 is upregulated by Ang II and hypoxic stress, and third, Nox4 plays a role in proliferation of brain pericytes.
Previous studies have reported conflicting results regarding the expression of the Nox homologue in pericytes. It was reported that Nox1, but not Nox2/gp91 phox , was predominantly expressed in pericytes isolated from the rat adipose-tissue microvasculature [28] . Previous studies suggested that ROS are produced via NADPH oxidase in retinal pericytes, which are thought to be analogous to brain pericytes, in response to some stimulants [29, 30] . It was shown that Nox2 (gp91 phox ) was expressed and localized in the cytosol of bovine retinal pericytes; however, the expression of other Nox family members, including Nox4, in these cells was not investigated [30] . In the present study, we have clearly shown that Nox4 is expressed in human brain pericytes and that Nox4 participates in ROS production by the membrane fraction of these cells. However, we cannot conclusively determine if the same Nox isoform is responsible in various organs. We found that Nox5, which is present in humans but not in rodents, was faintly expressed in human brain pericytes; however, the present study suggests little role for Nox5 in human brain pericytes. 
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The membrane fraction of human brain pericytes produced superoxide following the addition of NADH as well as NADPH. However, the addition of the cytosolic fraction had no effect on superoxide production. These features are in accordance with the typical characteristics of Nox4 [25] . To explore whether Nox4 is a major source of ROS in brain pericytes, we further investigated the production of ROS by inactivating the enzyme by pharmacological agents as well as RNAi. Superoxide-producing activity was almost abolished by DPI, an inhibitor of Nox enzymes, whereas inhibitors of other potential sources of superoxide had no effect on the superoxide-producing activity. Silencing of Nox4 significantly reduced superoxide production. Taken together, in brain pericytes, Nox4 appears to be a major source of NAD(P)H-dependent ROS production.
As one of the intrinsic regulators of Nox enzymes, Ang II occupies an important place in vascular pathophysiology. RAS plays a major role in vascular biology, particularly in relation to vascular disease. Ang II has diverse effects including vasoconstriction, oxidative stress, inflammation, endothelial dysfunction, impairment of neurovascular coupling, and vascular structure [31] . Blood vessels in the brain are constantly exposed to Ang II from both circulating and local sources. Ang II contributes to cerebrovascular diseases under conditions not only associated with hypertension but also with diabetes, arteriosclerosis, aging, and smoking. Moreover, RAS has been implicated in endothelial dysfunction and inflammation in cerebral microcirculation, through ROS production by Nox (Reviewed in [31] ). In the present study, the Ang II receptors were expressed in brain pericytes, and the addition of Ang II significantly increased Nox4 and p22 phox expression, suggesting that RAS works in pericytes through upregulation of Nox4 and p22
phox . Thus, in brain pericytes, Nox4 may be one of the key factors in the pathophysiology of cerebrovascular diseases.
Pericytes have been proposed to play a pivotal role during brain ischemia and in the post-stroke period through mechanisms such as contraction of pericytes [32] and angiogenesis [2, 6] . Hypoxic stress has been shown to induce ROS production in the brain [33] . In the present study, we found that Nox4 expression in human brain pericytes was upregulated under hypoxic conditions (1% (v/v) O 2 ). In addition, in non-ischemic mouse brain, the expression of Nox4 assessed by immunofluorescence was considerably low (data not shown), but was found clearly in the microvessels of peri-infarct area, suggesting that Nox4 may be upregulated under hypoxic condition also in vivo. These results raise the possibility that Nox4 in pericytes, upregulated in ischemic brain, has a role in pathophysiological process of brain ischemia, such as ROS-induced pericyte contraction and dysfunction, leading to the impairment of microcirculation in ischemic stroke [34] .
Nox4 was originally identified as an NADPH oxidase homologue highly expressed in the kidney [25, 35] . In addition to its strong expression in the kidney, Nox4 is also found in a variety of cells including vascular endothelial and smooth muscle cells [10, [20] [21] [22] 36] . Because Nox4 is also expressed in brain pericytes, the enzyme may have an important role in ROS production in the brain microcirculation. The function of Nox-derived ROS in the vascular system is complex and depends not only on the Nox isoform, but also on the cell type [17] . Overexpression of Nox1, one of the Nox family members, has been reported to increase the growth rate of NIH3T3 cells [37] . In the present study, Nox4 was also involved in the proliferation of human brain pericytes. Proliferation of pericytes is an essential event in angiogenesis, in which these cells are capable of guiding sprouting processes by migrating ahead of endothelial cells or maturing the newly formed capillaries [1, 6, 8] . Taken together, superoxide production through Nox4 in brain pericytes may be involved in angiogenesis in the brain by regulating the proliferation of cells. We should note that the present study had some limitation regarding the methods. We used the cell-free chemiluminescence method for evaluation of ROS production by pericyte membrane under the condition of NAD(P)H-dependency. Therefore, we should understand that the results were obtained under restricted conditions. It cannot be completely denied that ROS production by other pathways, such as electron leakage from the mitochondrial respiratory chain, nitric oxide synthases, and xanthine oxidases, have roles in human brain pericytes, in spite of using inhibitors of these pathways in this assay.
In conclusion, the present study revealed that Nox4 is a major source of superoxide production in human brain pericytes, and is regulated by Ang II and hypoxic stress in these cells. Nox4 in brain pericytes may have a central role in the pathophysiology of cerebrovascular diseases such as arteriosclerosis and ischemic stroke. Because pericytes are abundantly present in the brain vessels and are an important component of the neurovascular unit, Nox4 in brain pericytes may be a potential target for new therapies for cerebrovascular diseases.
